Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Zinc Supplements in Lowering Cadmium Levels in Smokers [Phase 2]
Phase 2 clinical trial evaluated zinc supplementation to lower cadmium levels in smokers; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating conditioning with alemtuzumab, busulfan, and cyclophosphamide followed by donor stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases [Phase 2]
Phase 2 trial evaluating donor peripheral stem cell transplant and donor natural killer cell transplant after conditioning with total-body i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in older patients with chronic lymphocytic leukemia. The study results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Bone Marrow Samples From Patients With Acute Leukemia
Completed clinical trial evaluating bone marrow samples from patients with acute leukemia.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Amplification and Selection of Antimicrobial Resistance in the Intestine
This update reports the completion of a clinical trial studying amplification and selection of antimicrobial resistance in the intestine, fo…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update investigating cord blood fucosylation to enhance homing and engraftment in patients with hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates [NA]
Clinical trial NCT01328873 reports completed results for FOB in hematopoietic stem cell transplant and leukemia patients with acute respirat…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety and pharmacology study of SNX-5422 in patients with refractory hematologic malignan…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial update for a CAR-T cell therapy in relapsed or refractory hematologic malignancies. It is sponsored by Hebei Senlan…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS safety_alert · 2017-04-17Clinical Trial Update: Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Clinical trial update reports methemoglobinemia risk in young patients with hematologic cancers or aplastic anemia treated with dapsone in a…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy [Phase 1]
This Phase 1 trial update reports on transplantation using specially treated bone marrow for hematologic cancers that have not responded to …
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) [Phase 2]
A Phase 2 trial of dasatinib in combination with the SMO antagonist BMS-833923 for leukemia was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders [Phase 2]
Phase 2 trial evaluating myeloablative conditioning with hyperfractionated total body irradiation plus thiotepa and fludarabine followed by …